Accès ouvert
2026
article
OpenAlex
Maya Graham Noer, Kimmie B. Christensen, Nanna S. Mikkelsen, Sigrid Fu Skjelbostad et autres
Acute myeloid leukemia (AML) remains a therapeutically challenging hematological malignancy with high relapse rates, especially in patients harboring mutations in the FMS-like tyrosine kinase 3 ( FLT3 ) gene. FLT3, a receptor tyrosine kinase involved in hematopoietic cell proliferation and survival, is …
dk
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Anne Marie Rosendahl Madsen, Frederik Schaltz‐Buchholzer, Ramona Trebbien, Rutger Jan Röring et autres
OBJECTIVES: The Bacillus Calmette-Guerin (BCG) vaccine has beneficial effects on the immune system, which may lead to non-specific protection against non-tuberculous infections and increase the response to subsequent vaccinations. Seasonal influenza vaccination is used to protect senior citizens against influenza, but the …
dk, Guinée-Bissau, nl
(code pays fourni par la source)
2026
conference-paper
OpenAlex
Anne Marie Rosendahl Madsen, Lise Gehrt, Torben Barington, Morten Bjerregaard-Andersen et autres
dk, de, nl, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Nina Marie Birk, Katrine Kielsen, Özcan Met, Eva Kannik Haastrup et autres
We report a case of severe encephalitis caused by human herpes virus 6 (HHV-6) following CD19 chimeric antigen receptor T (CAR-T) cell therapy. Rapid expansion of circulating T-lymphocytes and high HHV-6 viral load (4,500,000 DNA copies/mL) early after CAR-T infusion suggested HHV-6 …
dk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Emil Birch Christensen, Moritz Schaefer, Mike Bogetofte Barnkob, Christian B. Nielsen et autres
This 29-color flow cytometry panel was developed and optimized for in-depth characterization of human peripheral blood NK cells for preclinical development and monitoring of NK cell therapies. The panel includes markers associated with NK cell differentiation, cytotoxicity, tissue residency, as well as …
dk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Iman Chanchiri, Emil Birch Christensen, Niels Abildgaard, Torben Barington et autres
Multiple myeloma (MM) is a haematological malignancy originating from terminally differentiated B cells, resulting in significant morbidity and mortality. Currently, MM is regarded as an incurable disease, often exhibiting a relapse-remitting pattern that necessitates multiple lines of therapy. It is now well-established …
dk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob, Torben Barington
Chimeric antigen receptor (CAR) NK cell therapy has emerged as a promising alternative to CAR T cell therapy, offering significant advantages in terms of safety and versatility. Here we explore the current clinical landscape of CAR NK cells, and their application in …
dk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Zelvera Usheva, David Leander Petersen, Torben Barington, Peter Mouritzen et autres
The assessment of the cytotoxic potential of T cell-based therapies, such as chimeric antigen receptor (CAR) T cell treatments, is instrumental in assessing their efficacy and is a prerequisite for clinical application. However, traditional cytotoxicity assays are conducted as bulk assays and …
dk
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Anne Marie Rosendahl Madsen, Frederik Schaltz‐Buchholzer, Ramona Trebbien, Rutger Jan Röring et autres
dk, Guinée-Bissau, nl, us
(code pays fourni par la source)
2025
article
OpenAlex
Kimmie B. Colmorten, Zelvera Usheva, Julia Heiselberg, Mia Andersen et autres
Accès ouvert
2024
erratum
OpenAlex
Maria Ormhøj, Irene Scarfò, Maria L. Cabral, Stefanie R. Bailey et autres
Accès ouvert
2024
preprint
OpenAlex
Anne Marie Rosendahl Madsen, Lise Gehrt, Torben Barington, Morten Bjerregaard-Andersen et autres
dk, nl, Guinée-Bissau
(code pays fourni par la source)